e-learning
resources
Munich 2014
Sunday, 07.09.2014
Translational studies in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multi-analyte profiling of inflammatory markers in COPD sputum
F. Pedersen, G. Lauer, G. Quintini, O. Holz, A. M. Kirsten, H. Magnussen, K. F. Rabe, T. Goldmann, H. Watz (Grosshansdorf, Borstel, Hannover, Germany; Zürich, Switzerland)
Source:
International Congress 2014 – Translational studies in COPD
Session:
Translational studies in COPD
Session type:
Thematic Poster Session
Number:
837
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Pedersen, G. Lauer, G. Quintini, O. Holz, A. M. Kirsten, H. Magnussen, K. F. Rabe, T. Goldmann, H. Watz (Grosshansdorf, Borstel, Hannover, Germany; Zürich, Switzerland). Multi-analyte profiling of inflammatory markers in COPD sputum. Eur Respir J 2014; 44: Suppl. 58, 837
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
The U-BIOPRED severe asthma study: Immunopathological characterisation
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Proteomic investigation of pulmonary sarcoidosis
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Neutrophil degranulation responses in exacerbators and non-exacerbators of COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Comprehensive characterization of the lung proteasome
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Immunoaging augments sensitivity to cigarette smoke-induced COPD
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Different roles for PI3Kgamma and δ in asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Crosstalk between epithelium and fibroblasts; implications for COPD
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Validating SIK as a novel COPD target using four different human systems
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Process of pulmonary eosinophilia induced by intratracheal administration of Interleukin-33
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Quantitative immunohistochemical differences between catalase and thioredoxin in different anatomic compartments of the lung in severe COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Macrophage migration inhibitory factor (MIF), a biomarker in COPD?
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Detection of exosomal miRNA in pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
The airway microbiota is significantly altered in subjects with eosinophilic asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Association between airway inflammation, airway remodelling and physiological changes in asthma
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept